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Abstract
Burkholderia cenocepacia is an opportunistic bacterial pathogen that poses a signifi‐
cant threat to individuals with cystic fibrosis by provoking a strong inflammatory re‐
sponse within the lung. It possesses a type VI secretion system (T6SS), a secretory 
apparatus that can perforate the cellular membrane of other bacterial species and/or 
eukaryotic targets, to deliver an arsenal of effector proteins. The B. cenocepacia T6SS 
(T6SS‐1) has been shown to be implicated in virulence in rats and contributes toward 
actin rearrangements and inflammasome activation in B. cenocepacia‐infected mac‐
rophages. Here, we present bioinformatics evidence to suggest that T6SS‐1 is the 
archetype T6SS in the Burkholderia genus. We show that B. cenocepacia T6SS‐1 is 
active under normal laboratory growth conditions and displays antibacterial activity 
against	 other	Gram‐negative	bacterial	 species.	Moreover,	B. cenocepacia T6SS‐1 is 
not required for virulence in three eukaryotic infection models. Bioinformatics analy‐
sis identified several candidate T6SS‐dependent effectors that may play a role in the 
antibacterial activity of B. cenocepacia T6SS‐1. We conclude that B. cenocepacia 
T6SS‐1 plays an important role in bacterial competition for this organism, and prob‐
ably in all Burkholderia species that possess this system, thereby broadening the 
range of species that utilize the T6SS for this purpose.
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1  | INTRODUC TION
Bacteria utilize many systems to establish a niche, including mech‐
anisms to exploit eukaryotic organisms and/or to compete effec‐
tively with other bacterial species colonizing the same ecosystem. 
Many	 Gram‐negative	 bacteria	 possess	 a	 protein	 secretion	 sys‐
tem termed the type VI secretion system (T6SS) that participates 
in one or both processes, depending on the species (Ho, Dong, 
&	Mekalanos,	 2014).	 The	 T6SS	 is	 found	 in	 ~25%	 of	Gram‐nega‐
tive species (Bingle, Bailey, & Pallen, 2008), including the human 
pathogens Pseudomonas aeruginosa (Mougous et al., 2006), Vibrio 
cholerae (Pukatzki et al., 2006), Serratia marcescens (Murdoch et 
al., 2011), and Burkholderia pseudomallei (Burtnick et al., 2011). The 
system is composed of multiple copies of at least thirteen different 
subunits (TssA‐TssM) and a single copy of the PAAR protein, which 
are	organized	into	a	dynamic	protein	injection	machine	containing	
two distinct interacting subassemblies (Basler, 2015). The first is 
a contractile structure that shares homology with components of 
the T4 bacteriophage tail and is comprised of multimers of TssD 
(also termed Hcp) that assemble into a tube that is sharpened at 
one	end	by	a	trimer	of	TssI	(also	known	as	VgrG)	subunits	capped	
by a monomer of the PAAR protein. The tube, in turn, is surrounded 
by a contractile sheath composed of polymerized TssBC subunits. 
The tube–sheath structure is assembled on a platform known as 
the	baseplate	that	consists	of	the	TssEFGK	subunits	(Brackmann,	
Nazarov,	Wang,	 &	 Basler,	 2017;	 Brunet,	 Zoued,	 Boyer,	Douzi,	 &	
Cascales,	2015;	Leiman	et	al.,	2009;	Nguyen	et	al.,	2017).	The	sec‐
ond subassembly, composed of the TssJLM subunits, is a channel/
chamber complex that spans the inner membrane, periplasm, and 
outer membrane, and serves to anchor the contractile machinery 
to the bacterial cell envelope (Brunet et al., 2015; Durand et al., 
2015;	Nguyen	 et	 al.,	 2017).	 The	 role	 of	 the	 TssA	 subunit	 is	 less	
certain, but it has been proposed to play roles in priming and po‐
lymerization of the tube–sheath structure or act as a baseplate 
component (Planamente et al., 2016; Zoued et al., 2016).
Contraction of the sheath against the baseplate drives the 
sharpened inner tube through the chamber complex to the exterior 
where it punctures the cellular membrane of a neighboring target 
cell.	Effector	proteins,	which	may	be	noncovalently	associated	with	
the TssD, TssI, or PAAR subunits (“cargo” effectors) or occur as ad‐
ditional domains on these proteins (“specialized” effectors), are thus 
delivered into the target cell where they kill or subvert the recipient 
(Durand, Cambillau, Cascales, & Journet, 2014). In many T6SS‐con‐
taining bacteria, these targets are other competing species of bac‐
teria,	and	so	the	system	plays	a	major	role	in	bacterial	competition	
(Diniz & Coulthurst, 2015; Hood et al., 2010; MacIntyre, Miyata, 
Kitaoka, & Pukatzki, 2010; Schwarz et al., 2010). Such T6SS‐depen‐
dent competition can occur in a variety of environments, including 
plant	hosts	 (Ma,	Hachani,	Lin,	Filloux,	&	Lai,	2014)	or	the	mamma‐
lian gut (Chassaing & Cascales, 2018; Sana et al., 2016; Zhao, Caro, 
Robins, & Mekalanos, 2018). Some T6SSs also specifically target eu‐
karyotic cells and have more of a direct role in virulence, including 
the T6SS‐5 of B. pseudomallei and H2‐ and H3‐T6SS of P. aeruginosa 
(Burtnick et al., 2011; Jiang, Waterfield, Yang, Yang, & Jin, 2014; 
Sana et al., 2012).
A variety of T6SS‐dependent effectors and cognate immunity 
proteins have now been described, including superfamilies of an‐
tibacterial effectors. These include effectors that target the pepti‐
doglycan	 layer,	 phospholipid	 membrane,	 or	 host	 DNA/RNA,	 such	
as the amidase effector–immunity pairs termed Tae‐Tai (for type VI 
amidase effector/immunity; Hood et al., 2010; Russell et al., 2011; 
Russell	 et	 al.,	 2012;	 Fritsch	 et	 al.,	 2013),	 the	 type	VI	 lipase	 effec‐
tors (Tle) that possess phospholipase A1, A2, or D activity (Russell 
et	al.,	2013),	or	the	type	VI	DNase	effectors	(Tde;	Ma	et	al.,	2014),	
respectively. A number of anti‐eukaryotic effectors have also been 
described, including a P. aeruginosa effector with phospholipase D 
activity that can target both bacterial and eukaryotic cells (Jiang et 
al.,	 2014),	 the	 catalase	effector,	KatN,	 responsible	 for	 intramacro‐
phage survival of enterohemorrhagic E. coli (Wan et al., 2017), and a 
VgrG	subunit	with	a	C‐terminal	actin	cross‐linking	domain	utilized	by	
V. cholerae (VgrG‐1)	that	 impairs	the	phagocytic	activity	of	eukary‐
otic host cells (Ma, McAuley, Pukatzki, & Mekalanos, 2009; Pukatzki, 
Ma, Revel, Sturtevant, & Mekalanos, 2007).
The genus Burkholderia constitutes a large and diverse group of 
Gram‐negative	bacterial	species,	including	primary	and	opportunis‐
tic human pathogens, plant pathogens, and plant‐associated species 
with	 biocontrol	 properties	 (Eberl	 &	 Vandamme,	 2016).	 Recently,	
the classification of the Burkholderia has undergone a proposed re‐
vision, with all members of the Burkholderia cepacia complex (Bcc) 
and Pseudomallei groups, together with some phytopathogenic spe‐
cies, remaining as Burkholderia, while all the other species (typically 
nonpathogenic environmental strains) have been reassigned to the 
new genera Paraburkholderia	 (Sawana,	Adeolu,	&	Gupta,	2014)	and	
Caballeronia (Dobritsa, Linardopoulou, & Samadpour, 2017). The Bcc 
is a group of at least twenty closely related species that have gained 
notoriety as opportunistic respiratory pathogens in cystic fibrosis 
(CF)	patients,	as	some	strains	are	highly	transmissible	between	indi‐
viduals and the resulting infections can be difficult to treat effectively 
and result in fatal pneumonia and septicemia (Depoorter et al., 2016; 
Drevinek & Mahenthiralingam, 2010). One of the most prevalent Bcc 
species	 in	 CF	 infections	 is	B. cenocepacia. However, despite many 
studies investigating the virulence mechanisms of this bacterium, 
the molecular pathogenesis of B. cenocepacia infection is not fully 
understood.	Numerous	 strategies	 have	 been	 proposed	 to	 account	
for its virulence, including its ability to invade and survive intracel‐
lularly within host cells (Burns et al., 1996; Cieri, Mayer‐Hamblett, 
Griffith,	&	Burns,	2002;	Gavrilin	et	al.,	2012;	Martin	&	Mohr,	2000;	
McKeon, McClean, & Callaghan, 2010; Mesureur et al., 2017), induce 
pro‐inflammatory responses (Kotrange et al., 2011; Mesureur et al., 
2017), scavenge iron (reviewed in Butt & Thomas, 2017), and secrete 
hydrolytic enzymes such as zinc metalloproteases (Corbett, Burtnick, 
Kooi, Woods, & Sokol, 2003; Sokol et al., 2003).
As many as eight different T6SSs have been identified across the 
redefined Burkholderia genus, with anywhere up to six of them being 
encoded in the genome of an individual species (Angus et al., 2014; 
Shalom, Shaw, & Thomas, 2007). The six T6SSs in B. pseudomallei 
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have been described using two numbering systems (Schell et al., 
2007; Shalom et al., 2007), with a further two T6SSs identified in 
other Burkholderia species referred to as T6SSa and T6SSb (Angus et 
al., 2014). In the present investigation, we have adopted the nomen‐
clature of Shalom et al., 2007, and for consistency, we refer to T6SSa 
and T6SSb as T6SS‐7 and T6SS‐8, respectively. B. cenocepacia strains 
are generally considered to contain only a single T6SS that corre‐
sponds to T6SS‐1 of B. pseudomallei and B. thailandensis (Angus et al., 
2014;	Aubert,	Flannagan,	&	Valvano,	2008;	Aubert,	Hu,	&	Valvano,	
2015; Schwarz et al., 2010; Shalom et al., 2007).
The T6SS‐1 in the epidemic B. cenocepacia	CF	 isolate	K56‐2	was	
shown to contribute to bacterial survival within a rat model of chronic 
lung infection (Hunt, Kooi, Sokol, & Valvano, 2004). Subsequent work 
has suggested that T6SS‐1 is responsible for the ability of B. cenoce‐
pacia to subvert predatory eukaryotic cells, including the amoeba 
Dictyostelium discoideum and murine and human monocyte‐derived 
macrophages, and this involves actin cytoskeletal rearrangement 
(Aubert et al., 2008; Xu et al., 2014). The T6SS‐1 has been shown to 
exert	 its	 effect	 on	 cytoskeletal	 rearrangement	 through	Rho	GTPase	
inactivation	(Aubert	et	al.,	2008;	Flannagan	et	al.,	2012;	Keith,	Hynes,	
Sholdice, & Valvano, 2009; Rosales‐Reyes, Skeldon, Aubert, & Valvano, 
2012). More recent studies have suggested that the T6SS‐dependent 
interactions between B. cenocepacia and human‐derived phagocytic 
cells are important for triggering an innate immune response through 
pyrin	inflammasome	activation	upon	GTPase	inactivation,	which	may	
promote bacterial clearance and protection from potentially lethal in‐
fections	in	a	mouse	model	(Aubert	et	al.,	2016;	Gavrilin	et	al.,	2012;	Xu	
et al., 2014). Several observations which have been attributed to T6SS‐1 
activity have been obtained using a B. cenocepacia strain in which atsR, 
a gene encoding a hybrid sensor kinase, has been deleted. This results 
in upregulation of the system and allows for detection of T6SS‐1 secre‐
tion activity in a B. cenocepacia strain (Aubert et al., 2008, 2015).
Here, we present a bioinformatics analysis of the T6SS‐1 in the 
genus Burkholderia and related species. We demonstrate sufficient 
T6SS‐1 secretion activity in B. cenocepacia isolates growing under stan‐
dard laboratory conditions to investigate the role of the T6SS in this 
Bcc species, without the need for upregulation of the system by atsR 
inactivation.	From	this,	we	provide	evidence	to	support	a	 functional	
role of the T6SS‐1 in B. cenocepacia in bacterial competition through a 
series of bacterial competition assays. The contribution of the T6SS‐1 
to pathogenesis in three established eukaryotic models of B. cenoce‐
pacia infection was also investigated, but our results indicated that the 
system does not contribute to pathogenesis in these models.
2  | MATERIAL S AND METHODS
2.1 | Strains, plasmids, and growth conditions
The bacterial strains and plasmids used in this study are indicated 
in	 Table	A1	 (Appendix	 1).	 For	 cultivation	of	 bacteria,	 strains	were	
routinely grown in LB medium (E. coli, P. putida) or M9 minimal salts 
agar containing 0.5% glucose (B. cenocepacia) at 37°C. M9 minimal 
salts	 contained	42	mM	Na2HPO4, 22 mM KH2PO4,	 19	mM	NH4Cl, 
9	mM	NaCl,	1	mM	MgSO4, and 0.1 mM CaCl2. Antibiotics were used, 
when appropriate, at the following concentrations: ampicillin (Ap), 
100 μg/ml (E. coli); chloramphenicol (Cm), 25 μg/ml (E. coli, P. putida) 
and 50–100 μg/ml (B. cenocepacia); kanamycin (Km), 50 μg/ml (E. coli 
and B. cenocepacia); rifampicin (Rf), 100 μg/ml (E. coli and B. cenoce‐
pacia); and trimethoprim (Tp), 25 μg/mL (E. coli), 25 μg/ml (B. cenoce‐
pacia	H111	and	Pc715j),	and	100	μg/ml (B. cenocepacia K56‐2).	For	
selection of trimethoprim resistance in E. coli, Iso‐Sensitest Agar 
(Oxoid) was employed, and for selection of kanamycin resistance in 
B. cenocepacia, Lennox agar was utilized. Dialyzed brain‐heart infu‐
sion (D‐BHI) broth was prepared according to Sokol, Ohman, and 
Iglewski (1979) and used as the liquid growth medium for cultures of 
B. cenocepacia undergoing secreted protein extraction.
2.2 | DNA preparation and manipulation
Recombinant	 DNA	 techniques	 were	 performed	 essentially	 as	 de‐
scribed	 in	 Sambrook	 et	 al.	 (1989).	DNA	 amplification	 by	 PCR	was	
performed	with	KOD	DNA	polymerase	enzyme	(Millipore)	or	GoTaq	
G2	 Flexi	DNA	Polymerase	 (Promega)	 according	 to	manufacturer's	
instructions	using	boiled	cell	lysate	as	template	DNA.	Primers	used	
in this study are indicated in Table A2 (Appendix 1) and were pur‐
chased	 from	 Eurogentec,	 Belgium.	 PCR	 products	 were	 purified	
from solution or by agarose gel extraction using a QIAquick PCR 
Purification	Kit	(Qiagen).	DNA	restriction	enzymes	were	purchased	
from	Promega	or	New	England	Biolabs.	DNA	was	 ligated	using	T4	
DNA	ligase	(Promega).	Nucleotide	sequence	determination	was	per‐
formed	by	the	Core	Genomic	Facility	at	The	University	of	Sheffield,	
UK.	 Genome	 sequencing	 was	 provided	 by	 MicrobesNG	 (https://
www.microbesng.uk), Birmingham, UK. These sequence data have 
been	 submitted	 to	 the	 NCBI	 GenBank	 database	 under	 accession	
number MK051000. Details of data submission can be found at 
www.ncbi.nlm.nih.gov/genbank/.
2.3 | Construction of B. cenocepacia 
strains and plasmids
Burkholderia cenocepacia chromosomal mutants with insertion‐
ally inactivated genes were generated by allelic replacement using 
the	 suicide	 vector	 pSHAFT2,	 as	 previously	 described	 (Shastri	 et	
al.,	 2017).	 Briefly,	 DNA	 fragments	 containing	 ~1,200	bp	 of	 the	
N‐terminal	 coding	 region	of	 tssM (tssM’) and the entire tssK and 
tagY genes were amplified from B. cenocepacia H111 using primer 
pairs tssMfor and tssMrev, tssKfor and tssKrev, and tagYfor and 
tagYrev,	 respectively.	 Each	 gene/gene	 fragment	was	 cloned	 into	
the vectors pBBR1MCS or pBluescriptII, where tssK was cloned 
between the restriction sites HindIII and BamHI, tssM’ between 
XbaI and XhoI, and tagY between BamHI and XhoI, generating 
pBBR1‐tssK, pBBR1‐tssM’, and pBluescript‐tagY. To disrupt each 
target gene, pBBR1‐tssK was restricted with EcoRI, pBBR1‐tssM’ 
with BamHI, and pBluescriptII‐tagY with ZraI, and ligated to the 
trimethoprim (dfrB2) resistance cassette that was excised from 
p34E‐Tp	by	EcoRI, BamHI, and SmaI, respectively. The disrupted 
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alleles, tssK::Tp, tssM::Tp, or tagY::Tp, were then transferred to 
pSHAFT2	 as	 XhoI‐NotI (tssK and tssM) or XhoI‐XbaI (tagY ) frag‐
ments.	pSHAFT2‐derived	constructs	were	conjugated	into	B. ceno‐
cepacia	strains	H111,	K56‐2,	and	Pc715j	using	E. coli donor strain 
S17‐1(λpir) according to Herrero, Lorenzo, and Timmis (1990) and 
de Lorenzo and Timmis (1994) and selected using M9 agar contain‐
ing	 trimethoprim.	 The	previously	 constructed	pSHAFT2‐tssA::Tp	
plasmid	was	 similarly	 introduced	 into	K56‐2	and	Pc715j.	Double	
crossover recombinants were identified by chloramphenicol sen‐
sitivity and verified by PCR using primers pairs that annealed to 
genomic	 regions	of	 the	 target	 gene	 located	 just	 outside	 the	ho‐
mologous	 region	 contained	 within	 the	 pSHAFT2	 construct.	 See	
Appendix 2 for further details. Construction of the B. cenoce‐
pacia H111 tssM in‐frame deletion mutant has been described 
previously (Dix et al., 2018). The tssM complementation plasmid, 
pBBR1‐tssM(+), was constructed by amplifying tssM from B. ceno‐
cepacia H111 with primers tssMforAcc65I and tssMrevXbaI, and 
ligating the amplicon to the Acc65I and XbaI sites of pBBR1MCS, 
which places tssM under control of the vector lacZ promoter.
2.4 | Extraction and detection of 
extracellular proteins
Culture supernatants were collected from 15 ml D‐BHI broth cul‐
tures of B. cenocepacia strains grown at 37°C until at OD600 of 0.6–
0.8 and filter sterilized using a 0.22‐μM syringe‐driven filter unit. 
Sodium deoxycholate was added to supernatants to a final concen‐
tration of 0.2 mg/ml, which were then incubated on ice for 30 min. 
To precipitate proteins, TCA was added at 10% (w/v) final concen‐
tration	and	incubated	overnight	at	−20°C.	Supernatants	were	cen‐
trifuged to collect the protein pellets, which were then washed with 
acetone, collected by centrifugation, and air‐dried. Protein pellets 
were resolubilized with 15 μl of 1x SDS‐loading buffer (125 mM 
Tris‐HCl, 5% (w/v) SDS, 10% (v/v) glycerol, 5% (v/v) 2‐mercaptoeth‐
anol,	0.005%	(w/v)	bromophenol	blue,	pH	6.8).	For	cell‐associated	
protein fractions, the whole‐cell pellet was concentrated 20‐fold in 
PBS and combined with an equal volume of 2x SDS‐sample buffer.
Protein samples were separated in a 15% SDS–polyacrylamide 
gel, transferred onto 0.45‐μM	PVDF	membrane	(Millipore),	and	in‐
cubated for 1 hr in blocking solution (5% (w/v) milk, TBS, 0.05% 
(v/v) Tween‐20). TssD secretion was analyzed by Western blotting 
as standard protocol using a custom rat antibody raised against 
purified recombinant TssD (The University of Sheffield Biological 
Services, 1:2,000) and goat anti‐rat HRP secondary antibody 
(SouthernBiotech,	 1:5,000).	 RNA	 polymerase	 β‐subunit was de‐
tected	as	a	lysis	control	using	a	monoclonal	mouse	anti‐RNA	poly‐
merase β‐subunit	primary	antibody	(1:2,500,	NeoClone)	and	rabbit	
anti‐mouse HRP secondary antibody (Thermo Scientific, 1:5,000).
2.5 | Bacterial competition assay
Attacker (B. cenocepacia) and prey (e.g., P. putida, E. coli CC118(λpir)) 
strains	were	grown	overnight	in	LB	at	37°C.	Each	culture	was	then	
normalized to an OD600 of 0.5. Bacterial suspensions were combined 
in a 5:1 ratio of attacker:prey. Monoculture controls of target and 
attacker strains with LB were included using the same number of 
bacteria as in the attacker:prey sample, respectively. 25 μl of each 
coculture and control culture was spread over a 0.45‐μm nitrocellu‐
lose filter membrane on a prewarmed LB agar plate and incubated at 
30°C for 4 hr. After incubation, bacteria from each filter membrane 
were harvested in 1 ml LB and 10−1 to 10−5 serial dilutions made. 
10 μl of each dilution was spotted onto selection plates in triplicate 
using the surface viable count method (Miles, Misra, & Irwin, 1938). 
B. cenocepacia was selected by Tc resistance, P. putida by Cm resist‐
ance, E. coli CC118(λpir) by Rf resistance, and E. coli SM10(λpir) by Km 
resistance. Plates were incubated at either 37°C or 30°C overnight, 
dependent	on	the	strain.	The	number	of	viable	CFU	was	counted	and	
used	to	calculate	the	CFU/mL	for	each	coculture	or	control	culture	
tested. All experiments were carried out at least three times.
2.6 | Galleria mellonella larvae killing assay
Final‐instar	 Galleria mellonella larvae were purchased fresh from 
Livefood	UK	and	maintained	at	4°C	before	infection.	For	preparation	
of	bacteria	for	injection,	B. cenocepacia K56‐2 strains were cultured 
at 37°C in BHI broth until an OD600 of 0.6 was reached. The bacteria 
were centrifuged at 5,000 g for 2 min and resuspended in PBS to 
OD600	~0.5	and	serially	diluted.	For	determination	of	the	virulence	
of the strains, larvae (n	=	30)	were	injected	with	4	×	104	and	4	×	102 
CFU/larvae	 (in	10	μl) into the hindmost left proleg semi‐automati‐
cally using a PB‐600‐1 Repeating Dispenser (Hamilton) affixed to a 
Gastight	500‐μL	Hamilton	syringe	(Model	1750	RN	(large	hub)	SYR	
with	a	22‐gauge,	 large	hub	RN	NDL,	2	 inch,	point	 style	2	needle).	
Three control groups (n	=	20)	were	injected	with	10	μl of sterile PBS, 
10 μl heat‐killed bacteria (the lowest dilution of the bacterial culture 
used for infection boiled at 100°C for 10 min), or left untreated. 
Serial dilutions of the bacterial suspension were plated onto BHI 
agar and grown at 37°C overnight to estimate the bacterium inocu‐
lum. The heat‐killed bacterial suspension was also spotted onto BHI 
agar to check sterility. Larvae were incubated at 37°C for 26 hr in 
sterile plastic Petri dishes lined with filter paper discs. Larval survival 
was assessed from 16 to 26 hr postinfection at 2‐hr intervals. Dead 
larvae were classed as those that were stationary and no longer re‐
sponded to touch. All experiments were carried out at least three 
times.
2.7 | Caenorhabditis elegans killing assay
Analysis of the virulence of B. cenocepacia strains toward C. elegans 
N2	was	performed	as	described	 in	Uehlinger	et	al.	 (2009).	Briefly,	
to form a bacterial lawn, overnight cultures of B. cenocepacia strains 
were	 adjusted	 to	 a	 density	 of	 approximately	 1.3–1.5	×	104	CFU/
ml, and 100 μl of the suspension was plated onto six‐well plates 
containing	 nematode	 growth	 medium	 (NGM	 II)	 and	 incubated	 at	
37°C	 for	 24	hr.	 Following	 this,	 approximately	 20–40	 hypochlo‐
rite‐synchronized L4 larvae of C. elegans	Bristol	N2	(obtained	from	
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the Caenorhabditis	 Genetics	 Centre,	 University	 of	 Minnesota,	
Minneapolis) were used to inoculate the plates. Plates were then 
incubated at 20°C and the percentage of live worms scored after 
48	and	72	hr.	Nematodes	were	 considered	dead	when	 they	 failed	
to respond to touch. E. coli OP50 was used as a negative control. All 
experiments were carried out at least three times.
2.8 | Zebrafish embryo infection assay
Infection of zebrafish (Danio rerio) embryos was performed as 
described	 in	 Vergunst,	 Meijer,	 Renshaw,	 and	 O’Callagha	 (2010),	
Mesureur and Vergunst (2014). Briefly, B. cenocepacia K56‐2 and 
the otherwise isogenic tssM::Tp and tssA:Tp mutants were grown 
overnight in LB containing the appropriate antibiotics. Thirty hours 
postfertilization, zebrafish embryos were dechorionated and an‐
esthetized	 in	 E3	 medium	 with	 0.02%	 buffered	 tricaine	 methane‐
sulfonate	 (MS222).	Embryos	 (n	=	20)	were	then	microinjected	with	
around	100	CFU	of	bacteria	directly	 into	the	blood	circulation	and	
maintained	in	E3	medium	at	28°C.	Embryo	survival	was	monitored	at	
regular intervals from 40 hr postinfection (hpi). Dead embryos were 
scored as those without a heartbeat. The experiment was carried 
out twice.
From	 the	 same	 experiments,	 five	 infected	 embryos	 per	 treat‐
ment	group	were	taken	randomly	at	0	and	24	hpi	and	subjected	to	
bacterial enumeration as described in Mesureur & Vergunst, 2014. 
Statistical	analysis	was	performed	using	Prism	6	(GraphPad).	Survival	
assays are represented in Kaplan–Meier graphs and analyzed with a 
log‐rank	(Mantel–Cox)	test.	In	CFU	count	experiments,	significance	
was	determined	using	one‐way	ANOVA,	with	Sidak's	multiple	com‐
parison test.
2.9 | Bioinformatic analysis
Relevant	 DNA	 and	 protein	 sequences	 were	 obtained	 from	 the	
NCBI	GenBank	database	(Clark,	Karsch‐Mizrachi,	Lipman,	Ostell,	&	
Sayers,	2016).	Unannotated	GenBank	entries	were	manually	 inter‐
rogated for coding regions and the respective protein sequences 
using	SnapGene®	 software	 (from	GSL	Biotech;	 available	 at	 http://
www.snapgene.com). All protein homology analyses were per‐
formed	using	NCBI	blastp	and	the	nonredundant	protein	sequences	
(nr) database. T6SS‐1 clusters were identified in a two‐step process. 
First,	the	amino	acid	sequences	of	TssH	(BCAL0347)	and	TagX	pro‐
teins (BCAL0352) from B. cenocepacia J2315 were used as search 
queries to identify homologous proteins. Second, the loci encoding 
these proteins were interrogated for the presence of other T6SS‐re‐
lated genes. If homologues of the additional tag genes tagM, tagN, 
and tagY and	 the	majority	of	 core	 tss genes were present, the re‐
gion was defined as a T6SS‐1 cluster. To identify T6SS‐7 clusters, 
the protein sequence of the TssH homologue in the H111 T6SS‐7 
cluster (I35_RS17330) was used as the query sequence to identify 
homologous	proteins	with	a	percentage	sequence	identity	≥70%	in	
Burkholderia and Paraburkholderia species. The surrounding loci were 
then interrogated. If homologues of the core tss genes (tssA‐tssM) 
were present in a similar genetic arrangement as that in the H111 
T6SS‐7 cluster, the region was defined as a T6SS‐7 cluster.
Multiple sequence alignments were performed using Clustal 
W or Clustal Omega (Larkin et al., 2007; Sievers et al., 2011) and 
formatted for display using BoxShade (https://www.ch.embnet.
org/software/BOX_form.html). The prediction of transmembrane 
helices within proteins was performed using TMHMM Server v.2.0 
(Krogh,	Larsson,	Heijne,	&	Sonnhammer,	2001).
3  | RESULTS
3.1 | Comparative analysis of the T6SS‐1 in 
Burkholderia and non‐Burkholderia species
In a previous study, six T6SSs were identified in B. pseudomallei 
(Shalom et al., 2007). The only one encoded on the large chromosome 
(T6SS‐1) has been identified in nine other Burkholderia species and 
three members of the Paraburkholderia (Angus et al., 2014). We have 
extended this analysis to include all Burkholderia and Paraburkholderia 
species, and members of other related proteobacteria for which ge‐
nome sequence information is available. Therefore, the amino acid 
sequence of protein products encoded by the T6SS‐1 gene cluster 
of B. cenocepacia J2315 was used in blastp searches to identify ho‐
mologous proteins in other Burkholderia, Paraburkholderia, and related 
species, and the respective T6SS‐1 gene clusters that encoded them 
were identified. All members of the genus Burkholderia (i.e., the Bcc 
and pseudomallei groups and the phytopathogenic strains B. gladioli, 
B. plantarii, and B. glumae), with the exception of the recently described 
species B. singularis, were found to harbor the T6SS‐1 gene cluster 
(Table A3 in Appendix 1). In species for which a complete genome 
assembly was available, the T6SS‐1 was located on chromosome 1 in 
every case. We also found homologous loci of the Burkholderia T6SS‐1 
gene cluster in many species of the closely related Paraburkholderia 
genus, including P. acidipaludis, P. phytofirmans, and P. fungorum (see 
Table A4 in Appendix 1 for additional species), several of which were 
located on chromosome 2 or 3 instead of chromosome 1. The T6SS‐1 
cluster of P. acidipaludis	is	shown	in	Figure	1.	A	T6SS‐1	cluster	with	a	
similar, but not identical, genetic organization was also found in other 
β‐proteobacteria, including Ralstonia solanacearum, Rubrivivax gelati‐
nosus, Achromobacter xylosoxidans, and the γ‐proteobacteria species 
Xanthomonas oryzae and Acinetobacter baumannii (Figure	1).
Most clusters were found to contain the core tss genes on three 
closely	linked	transcriptional	units.	However,	in	the	majority	of	Bcc	
species, genes encoding the core T6SS subunits TssI and PAAR were 
not observed to be located in the T6SS‐1 gene cluster and are in‐
stead present in multiple copies at other loci distributed through‐
out the genome (as observed for B. cenocepacia by Aubert et al., 
2015). Curiously, the T6SS‐1 gene cluster of members of the genus 
Acinetobacter lacked a copy of the core tssJ gene, as previously noted 
(Weber et al., 2013). It was also observed that several T6SS‐1 clus‐
ters contained insertions of one or more additional genes between 
the core genes or translocations of gene blocks, such as those in 
B. multivorans, P. acidipaludis, and R. solanacearum	(Figure	1).
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Type VI‐associated genes (tag) are conserved in some T6SSs but 
not others and encode proteins related to T6SS function, such as reg‐
ulators or auxiliary subunits (Aschtgen, Thomas, & Cascales, 2010; 
Lossi	et	al.,	2012;	Shalom	et	al.,	2007;	Silverman	et	al.,	2011).	Five	
tag genes were recognized as being conserved in almost all T6SS‐1 
clusters. These are tagF, which encodes a post‐translational regulator 
and is also present in some unrelated T6SSs such as the H1‐T6SS of 
P. aeruginosa (Lin et al., 2018; Silverman et al., 2011); tagM, encoding 
a putative outer membrane‐anchored lipoprotein of unknown func‐
tion (Shalom et al., 2007); tagN,	encoding	a	putative	PG‐anchoring	
protein (Aschtgen et al., 2010); tagX, encoding a Sec‐dependent 
membrane‐anchored peptidoglycan hydrolase that facilitates T6SS 
sheath assembly through formation of holes in the peptidoglycan 
layer (Aubert et al., 2015; Ringel, Hu, & Basler, 2017; Weber et al., 
2016); and a previously undescribed gene referred to here as tagY.
tagY corresponds to BCAL0353 in B. cenocepacia J2315 and is 
located upstream from tagX, but in the reverse orientation in nearly 
all	 T6SS‐1	 gene	 clusters	 (Figure	 1).	 It	 does	 not	 occur	 in	 unrelated	
T6SS gene clusters. In most Burkholderia species, tagY is likely to 
constitute a monocistronic operon due to the presence of a putative 
Rho‐independent transcription termination sequence located down‐
stream from the tagY coding sequence, but in some non‐Burkholderia 
species, it constitutes the first gene of a polycistronic operon that 
encodes additional T6SS‐related proteins such as TssI and putative 
Tle	effectors	(Figure	1).	Therefore,	TagY	is	likely	to	play	a	role	in	the	
activity of T6SS‐1. It should be noted that tagM and tagY are not 
present in the Acinetobacter T6SS‐1 gene cluster. As members of this 
genus also appear to lack a TssJ orthologue, they are devoid of three 
periplasmic proteins that are present in the Burkholderia‐type T6SS‐1 
in other species.
Analysis of the predicted protein product of tagY orthologues 
identified a putative transmembrane domain (TMD) located approx‐
imately	55	residues	from	the	N‐terminus.	The	region	located	N‐ter‐
minal to the TMD contains two short conserved motifs separated 
F I G U R E  1  Gene	arrangement	and	distribution	of	the	Burkholderia	T6SS‐1	gene	cluster.	Schematic	representation	of	the	Burkholderia 
T6SS‐1 gene cluster and related gene clusters in members of the Proteobacteriaceae. The box shows the genetic organization of the 
archetype Burkholderia T6SS‐1 gene cluster harbored by the indicated species, including B. cenocepacia (for reference, the B. cenocepacia 
T6SS‐1 gene cluster corresponds to BCAL0337‐BCAL0353 in strain J2315 and I35_RS01700‐I35_RS01780 in H111, as indicated). 
Variations on the same basic theme found in other members of the Burkholderia, related genera within the β‐proteobacteria (Achromobacter, 
Paraburkholderia, Ralstonia, and Rubrivivax), and some members of the γ‐proteobacteria (Acinetobacter, Xanthomonas) are shown
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by	10–13	amino	acids	(Appendix	Figure	A1).	Based	on	the	“positive	
inside	 rule”	 (Elofsson	&	 von	Heijne,	 2007),	 the	presence	of	 amino	
acid	 residues	 with	 basic	 side	 chains	 immediately	 N‐terminal	 to	
the	 TMD	 suggests	 that	 the	 N‐terminal	 region	 constitutes	 a	 small	
cytoplasmically located domain. The TMD is followed by a long 
linker‐like region of low complexity, which in TagY orthologues in 
the Burkholderia spp. shares homology to the RnfC barrel sandwich 
hybrid	domain	 (cl26195),	a	domain	found	at	 the	N‐terminus	of	 the	
RnfC electron transport complex subunit in Rhodobacter capsulatus 
(Biegel,	Schmidt,	González,	&	Müller,	2011;	Schmehl	et	al..,	1993).	A	
conserved C‐terminal region of ~40 amino acids that contain four 
cysteine residues was identified in most TagY orthologues (Appendix 
Figure	A1).	Due	to	the	known	role	of	cysteine	thiols	in	various	cel‐
lular activities, it is possible that this part of the protein, which is 
predicted to be located in the periplasmic space, constitutes a do‐
main which assembles an iron–sulfur cluster. Alternatively, it may be 
involved in binding other transition metal ions such as zinc or copper, 
or act as a redox sensor.
Two additional genes are conserved in the T6SS‐1 cluster of spe‐
cies that are not members of the Burkholderia and Paraburkholderia 
genera. They correspond to RSp0764 and RSp0765 of R. sola‐
nacearum	GM1000,	 RGE_RS12595	 and	RGE_RS12600	of	R. gelati‐
nosus IL144, XOO3320 and XOO3321 of X. oryzae	MAFF	311018,	
AT699_RS16195, and an unannotated gene of A. arsenitoxydans 
NCTC10807,	 and	 ABAYE2409	 and	 ABAYE2405	 of	 A. bauman‐
nii (which were previously annotated as asaB and asaC as they 
were thought to be unique to the Acinetobacter T6SS; Carruthers, 
Nicholson,	Tracy,	&	Munson,	2013).	Bioinformatic	analysis	predicts	
that the first of each pair of genes encodes a protein possessing 
TMDs	close	 to	 the	N‐terminus	 (Appendix	Figure	A2),	whereas	 the	
latter has been recognized as a putative PAAR domain‐containing 
protein in A. baylyi and named accordingly (Weber et al., 2016). 
Homologues of the asaB gene (from herein referred to as tagZ) 
are also present in some, but not all Burkholderia and in a single 
Paraburkholderia species (P. bannensis), while paar is present in all 
Burkholderia and Paraburkholderia species. However, both genes 
reside outside the T6SS‐1 cluster in these two genera and in some 
cases are located within a conserved gene cluster on chromosome 
1 that encodes three TssI subunits and one or more effector–im‐
munity	protein	pairs	 (Appendix	Figure	A3).	The	gene	encoding	the	
PAAR domain protein is located immediately upstream of tagZ in 
these T6SS‐related gene clusters, as is the case where these genes 
occur	in	the	main	T6SS‐1	gene	cluster	(Figure	1).	As	a	number	of	the	
Burkholderia and Paraburkholderia species possess only T6SS‐1, it can 
be concluded that despite its location outside of the main T6SS‐1 
gene cluster, the products of the paar‐tagZ gene pair play a role in 
the activity of T6SS‐1.
3.2 | Identification of an additional, isolate‐specific, 
type VI secretion system in Burkholderia cenocepacia
During the bioinformatic analysis of the T6SS‐1 described above, 
an additional, complete T6SS gene cluster was identified in 
B. cenocepacia strain H111, a cystic fibrosis isolate (Carlier et al., 
2014;	Geisenberger	et	al.,	2000).	Further	genome	mining	revealed	
that it was also present in B. cenocepacia	strains	FL‐5‐3‐30‐S1‐D7,	
VC12308,	and	DWS	37E‐2,	and	several	additional	B. cenocepacia 
isolates for which only contig or scaffold‐level genomic data are 
currently	 available,	 including	D2AES,	 PC148,	 and	 TAtl‐371	 (see	
Table A5 in Appendix 1 for loci). This second T6SS cluster is lo‐
cated on chromosome 2 in the completely sequenced strains and 
encodes orthologues of all the core T6SS subunits, including TssI 
and	 PAAR	 (Figure	 2).	 The	 cluster	 shares	 a	 genetic	 arrangement	
that is similar to a T6SS cluster present in the plant pathogenic 
F I G U R E  2    Burkholderia cenocepacia H111 possesses an additional T6SS that is present in some plant‐associated and human pathogenic 
bacteria. Schematic representation of a T6SS gene cluster identified in B. cenocepacia H111 (top) (I35_RS17325–I35_RS17415), which has a 
similar genetic organization to the T6SS‐7 cluster (also known as T6SS‐a) previously identified in B. glumae	BGR1	and	P. tuberum DUS833. 
A related T6SS cluster is also present in C. metallidurans CH34,	EAEC	042	(the	T6SS‐1	or	sci‐1 cluster), and Y. pseudotuberculosis IP 32953 
(T6SS‐2)
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Burkholderia species, B. glumae, and to a T6SS gene cluster pre‐
sent in several Paraburkholderia species, including P. tuberum, 
which has been referred to as T6SSa (Angus et al., 2014), but for 
consistency with the established nomenclature is referred to here 
as the Burkholderia T6SS‐7. Our analysis also identified T6SS‐7 
clusters in some but not all isolates of other Bcc species and in 
Cupriavidus metallidurans, a species that is closely related to the 
Burkholderia/Paraburkholderia clade (Table A5 in Appendix 1 and 
Figure	2).
Burkholderia T6SS‐7 is notable in possessing a TagL orthologue 
which serves as an auxiliary subunit that anchors the T6SS to the 
peptidoglycan (Aschtgen et al., 2010). Accordingly, the genetic orga‐
nization of this T6SS gene cluster is also similar to those encoding 
TagL‐dependent T6SSs present in human pathogens such as T6SS‐2 
of Yersinia pseudotuberculosis, the T6SS of the uropathogenic E. coli 
strain	 CFT073,	 and	 the	 T6SS‐1	 (Sci‐1	 T6SS)	 of	 enteroaggregative	
E. coli (Figure	2).
Bioinformatic analysis of the T6SS‐7 gene cluster also suggests 
that it encodes a phospholipase D (PLD) effector and two corre‐
sponding Tli immunity proteins in members of the Burkholderiaceae. 
This particular PLD belongs to the Tle5 group of phospholipase 
effectors and is closely related to the PldB protein, PA5089, en‐
coded by the H3‐T6SS of P. aeruginosa that has been shown to serve 
as a transkingdom effector (Russell et al., 2013; Jiang et al., 2014; 
Appendix	Figure	A4).
3.3 | The Burkholderia cenocepacia T6SS‐1 
is functional during growth under standard 
laboratory conditions
The presence of the core T6SS subunit, TssD, in bacterial cul‐
ture supernatants is the hallmark of an active T6SS and can be 
used as a method to determine functionality of the T6SS. This 
assay was used to determine whether B. cenocepacia isolates 
possess an active T6SS‐1 during growth under standard labora‐
tory conditions and to validate T6SS‐1 mutants prior to their use 
in bacterial competition and virulence assays described below. 
Therefore, mutants defective in the core tssA, tssK, and tssM 
components of T6SS‐1 were generated in strains H111, K56‐2, 
and	 Pc715j,	 and	 TssD	 secretion	 of	 the	mutants	was	 compared	
to that of the corresponding wild‐type parent strains grown in 
broth culture.
Western blotting showed that TssD was absent in the culture 
supernatant of the tssA, tssK, and tssM mutants but present in the 
respective wild‐type H111 and K56‐2 supernatants consistent with 
previous results obtained using a B. cenocepacia atsR mutant (Aubert 
et	al.,	2015;	Figure	3a).	The	H111	and	K56‐2	tssM mutants were sub‐
jected	to	a	complementation	analysis,	whereby	TssD	secretion	could	
be restored in both strains by introduction of a plasmid expressing 
tssM	(Figure	3b).	Together,	these	results	indicate	that	B. cenocepacia 
isolates H111 and K56‐2 have an active T6SS‐1 under standard lab‐
oratory conditions.
The additional B. cenocepacia	isolate	analyzed,	Pc715j	(and	its	
T6SS‐deficient derivatives), was unable to secrete TssD into the 
extracellular milieu, despite detection of this protein in whole‐cell 
extracts	 (Figure	 3a),	 indicating	 that	 TssD	 was	 being	 expressed	
but that the T6SS‐1 was incapable of firing and/or assembly in 
this strain. Whole‐genome sequencing of our laboratory stock 
of	 Pc715j	 indicated	 that	 an	 IS	 element	 was	 inserted	 into	 the	
tssM gene. The IS element exhibited homology to the ISUmu23 
insertion sequence found in the Bcc‐specific phage KS5 (Lynch, 
Stothard, & Dennis, 2010), and its insertion into the tssM coding 
sequence was predicted to result in production of a nonfunctional 
truncated form of the TssM subunit that lacked the C‐terminal 447 
amino acids.
The role of the candidate post‐translational regulatory protein, 
TagY, in T6SS‐1 activity was also explored by inactivating the tagY 
gene in strain H111. However, no significant difference in TssD se‐
cretion was observed between the wild‐type and the mutant strains 
(results not shown). These results could be explained if TagY acts to 
further upregulate the system in response to an unknown signal that 
is not present under the assay conditions.
F I G U R E  3    Burkholderia cenocepacia T6SS‐1 is active under standard laboratory conditions. Secretion activity of B. cenocepacia T6SS‐1 
in	vitro.	Anti‐TssD	immunoblot	was	performed	on	proteins	extracted	from	culture	supernatants	(SN)	and	cell‐associated	proteins	(CA)	of	
B. cenocepacia wild‐type	(WT)	strains	H111,	K56‐2,	and	Pc715j,	and	corresponding	T6SS‐1	mutants	(tssA::Tp, tssK::Tp, tssM::Tp, and/or ΔtssM) 
(a) and the H111 and K56‐2 WT and ΔtssM or tssM::Tp strains carrying a complementation or empty control plasmid (pBBR1‐tssM(+) and 
pBBR1MCS (“pBBR1”), respectively) (b). Anti‐β‐RNAP	antibody	was	used	as	an	indicator	of	bacterial	cell	lysis	in	preparations.	Scales	and	
labels as indicated. The H111 tssA::Tp mutant was included as a control
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3.4 | Burkholderia cenocepacia T6SS‐1 exhibits 
antibacterial activity
It has been demonstrated that the T6SS can target effector proteins 
to other bacteria, thereby helping the organism to compete more ef‐
fectively against other bacterial species in its growth environment. 
However, to date, the antibacterial nature of the T6SS‐1 in any mem‐
ber of the Bcc has not been reported. Therefore, we addressed the 
role of the T6SS‐1 in the ability of B. cenocepacia to compete effec‐
tively with other bacterial species.
As basal‐level TssD secretion appeared to be greater in B. ceno‐
cepacia H111	than	in	strain	K56‐2	(Figure	3a),	the	former	was	cho‐
sen to evaluate the role of the T6SS‐1 in competition in this species. 
Strains H111 and H111‐ΔtssM were used as “attackers” in a bacte‐
rial	 competition	 experiment	 against	 Gram‐negative	 “prey”	 species	
Pseudomonas putida KT2440, Escherichia coli CC118(λpir), and E. coli 
SM10(λpir).	Following	cocultivation	for	four	hours	on	solid	medium,	
viable prey bacteria were enumerated and the number that survived 
attack by the wild‐type and mutant attackers were compared.
For	all	three	prey	strains	tested,	the	number	of	recovered	sur‐
viving prey bacteria was significantly lower (by one to two orders of 
magnitude) when they were cocultured with the wild‐type attacker 
strain in comparison with no attacker, demonstrating that B. ceno‐
cepacia can restrict the growth of E. coli and P. putida	 (Figure	4a).	
Furthermore,	 following	coculture	with	 the	ΔtssM attacker strain, 
the number of surviving prey bacteria was similar to those ob‐
served	when	no	attacker	was	present	(Figure	4a).	The	number	of	
recoverable attacking H111 bacteria was similar for both the WT 
and T6SS mutant strains and was unaffected by coculture with 
all	 prey	 strains	 (Appendix	 Figure	 A5).	 To	 validate	 these	 results,	
a complementation experiment was performed using the E. coli 
SM10(λpir) strain as the prey. The antibacterial activity of the tssM 
mutant attacker toward the E. coli strain could be restored to wild‐
type levels by introduction of a plasmid expressing tssM into the 
mutant	 attacker	 strain	 (Figure	 4b).	 These	 data	 strongly	 suggest	
that the T6SS‐1 in B. cenocepacia has antibacterial properties.
3.5 | Burkholderia cenocepacia T6SS‐1 is not required 
for virulence in eukaryotic models of infection
Several eukaryotic infection models have been used to identify viru‐
lence factors of B. cenocepacia, including the nematode C. elegans, 
larvae of the waxmoth G. mellonella, and zebrafish embryos (Seed 
& Dennis, 2008; Uehlinger et al., 2009; Vergunst et al., 2010). To 
F I G U R E  4   The Burkholderia cenocepacia T6SS‐1 plays a role in bacterial competition. (a) Recovery of viable P. putida, E. coli SM10(λpir) 
and E. coli CC118(λpir)	(in	CFU/ml)	“prey”	strains	following	coculture	with	the	indicated	B. cenocepacia H111 “attacker” strains for 4 hr at 
30°C. (b) Comparison of recovery of E. coli SM10(λpir) prey following coculture with B. cenocepacia H111 WT or ΔtssM mutant attacker 
strains	carrying	complementation	or	control	plasmids	pBBR1‐tssM(+)	(“ptssM”)	and	pBBR1MCS	(“pBBR1”),	respectively.	n	≥3	and	error	bars	
indicate SD
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ascertain the contribution of T6SS‐1 to the virulence of B. cenoce‐
pacia, we utilized all three of these infection models. Comparison of 
the survival of C. elegans infected with B. cenocepacia strain H111 
and its tssA and tssK mutant derivatives for 48 and 72 hr showed 
that the wild‐type and mutant strains exhibited a similar killing ef‐
ficiency	during	both	time	periods	(Figure	5a).	tssA and tssM mutants 
of strain K56‐2 were used to explore the role of T6SS‐1 in virulence 
toward G. mellonella larvae and zebrafish embryos. Comparison of 
the survival of G. mellonella following infection with these mutants 
demonstrated that they were able to kill the larvae as effectively 
as the wild‐type strain at 24 hr postinfection, whether high or low 
bacterial	 loads	 were	 employed	 (4	×	104	 and	 4	×	102	 CFU/larvae,	
respectively),	 (Figure	 5b).	Wild‐type	K56‐2	 and	 its	 T6SS‐1	mutant	
derivatives were also found to be similarly virulent in the zebrafish 
model, both in terms of mortality and multiplication of the bacteria 
in	 the	 host	 (Figure	 5c).	 Taken	 together,	 these	 results	 suggest	 that	
the T6SS‐1 in B. cenocepacia is primarily used to target other bac‐
terial species. Although T6SS‐1 does not significantly contribute to 
F I G U R E  5   The Burkholderia cenocepacia T6SS‐1 is not required for virulence toward eukaryotes. (a) Percentage survival of C. elegans 
following 48‐hr (white bars, left) and 72‐hr (black bars, right) infection with the indicated B. cenocepacia H111 strains at 20°C. Twenty to 40 
worms were used per condition. E. coli	OP50	was	used	as	a	negative	control.	Each	point	indicates	mean	(n = 3), and error bars indicate SD. 
(b)	Percentage	survival	of	wax	moth	larvae	following	24‐hr	infection	with	high	(1	×	104)	(left)	and	low	(1	×	102) (right) doses of B. cenocepacia 
K56‐2 (WT) and indicated mutant strains at 37°C. Thirty larvae were infected per condition. Uninfected (UI), heat‐killed B. cenocepacia WT 
(HK),	and	mock‐infected	(PBS)	controls	were	included.	Each	point	indicates	mean	%	survival	(n = 3), and error bars indicate SD. (c) Zebrafish 
embryos	were	microinjected	with	~100	CFU	of	indicated	B. cenocepacia	K56‐2	strains	and	kept	at	28°C	in	individual	wells	containing	E3	
medium. About 20 embryos were used for determination of survival percentage over time (representative experiment shown on the left), 
and five embryos per indicated time point were used to determine recovery of viable B. cenocepacia K56‐2 counts (n = 5 per time point per 
experiment, geometric mean; right‐hand graph, showing summary of two independent experiments). ns: not significant
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virulence in the eukaryotic models tested here, it is possible that it 
may have an impact in other systems.
3.6 | In silico identification of putative T6SS‐
dependent effectors in B. cenocepacia
The T6SS‐1 cluster in B. cenocepacia encodes no obvious T6SS‐de‐
pendent effectors. However, an earlier bioinformatics survey of the 
B. cenocepacia K56‐2 genome identified ten TssI proteins encoded 
at other locations within the genome, of which two (BCAL1359 and 
BCAS0667) contain C‐terminal effector domains (Aubert et al., 2015). 
Here, using what is known from previously characterized T6SS‐de‐
pendent effectors, coupled with bioinformatic tools, we have identi‐
fied additional putative T6SS‐dependent non‐TssI effectors and their 
cognate immunity proteins encoded by the B. cenocepacia genome. 
As T6SS‐dependent effector genes in other species are often located 
within close proximity to tssI genes (Lien & Lai, 2017), we used the 
predicted amino acid sequences of protein products encoded within 
close proximity to the ten intact tssI genes and one disrupted tssI gene 
(BCAL2503) present within the B. cenocepacia J2315 genome as que‐
ries in BLASTP searches to identify putative functional domains and 
homology to proteins belonging to established T6SS effector super‐
families	(Appendix	Figure	A6).	Twelve	putative	T6SS	effectors	were	
identified using this approach, with each of the tssI clusters in B. ceno‐
cepacia J2315 encoding at least one putative effector. Of the putative 
effectors identified, six were predicted to be phospholipases (encoded 
by BCAL1296, BCAL1358, BCAL1366, BCAL2277, BCAM0046, and 
BCAM0149), five of which belong to the Tle antibacterial effector 
superfamily (Russell et al., 2013). Of the six remaining effectors, one 
is a predicted peptidoglycan hydrolase (BCAL1166), two were identi‐
fied as putative nuclease effectors (BCAL1298 and BCAS0663), of 
which the latter contains RHS repeats, an additional RHS repeat pro‐
tein	(BCAM2253)	containing	a	RES‐type	NAD+ glycohydrolase CTD 
(Skjerning,	Senissar,	Winther,	Gerdes,	&	Brodersen,	2018),	and	two	
homologues of the antibacterial pore‐forming toxin Tse4 (BCAL1292 
and BCAL2505; Whitney et al., 2014; LaCourse et al., 2018) were 
also identified. An additional putative T6SS effector was identified 
by using homologues of the Tae peptidoglycan hydrolase T6SS effec‐
tor superfamilies as queries to search the entire translated genome 
of B. cenocepacia, resulting in identification of a Tae4‐Tai4 effector 
immunity pair (BCAM1464‐BCAM1465) located away from a tssI 
gene	 cluster.	 Further	 details	 of	 the	 putative	 T6SS	 effectors	 identi‐
fied in these searches are included in Table A6 in Appendix 1, which 
includes the specific domains identified and putative immunity pro‐
teins. It should be noted that the previously described TecA effector 
(Aubert et al., 2016) is not encoded within a tssI gene cluster and was 
not independently identified in our analysis.
4  | DISCUSSION
Although some species of bacteria, such as S. marcescens and V. chol‐
erae V52, do exhibit high basal levels of T6SS activity during growth 
in	 laboratory	media	 (Gerc	 et	 al.,	 2015;	MacIntyre	 et	 al.,	 2010),	 in	
other cases the T6SS is observed to be inactive (Burtnick et al., 2011; 
Mougous et al., 2006; Zheng, Shin, Cameron, & Mekalanos, 2010), 
necessitating the use of bacterial strains that have a constitutively 
active T6SS in order to investigate the functional role of the system 
and aid in the identification of T6SS‐dependent substrates (Hood et 
al., 2010; Russell et al., 2011). Here, we demonstrate that the T6SS‐1 
of B. cenocepacia is active under standard laboratory conditions with 
sufficient basal activity to allow detection of TssD in concentrated 
culture supernatant by immunoblotting. This observation is consist‐
ent with a previous proteomic study in which a protein identified as 
“hemolysin‐coregulated protein” (i.e., Hcp or TssD) was detected in 
the	extracellular	fraction	of	strain	H111	through	2‐DE	coupled	mass	
spectrometry which was not recognized as a T6SS subunit at the time 
(Riedel,	Carranza,	Gehrig,	Potthast,	&	Eberl,	2006).	These	results	are	
also consistent with an investigation that demonstrated TssD secre‐
tion in strain K56‐2 could be increased upon inactivation of a global 
virulence regulator, atsR (Aubert et al., 2008). This study showed the 
presence of very small amounts of a protein corresponding in size to 
TssD	in	wild‐type	K56‐2	culture	supernatants	by	SDS‐PAGE,	which	
was confirmed by mass spectrometry rather than immunoblotting, 
as in our study. Moreover, the low abundance of this protein in the 
secreted fraction led the authors to consider the T6SS activity to be 
insufficient to use the wild‐type strain in further investigations into 
the role of the T6SS in B. cenocepacia. It is possible that our method 
of sample preparation and detection in wild‐type K56‐2 was more 
sensitive than that used in the Aubert and co‐workers study.
The role of the T6SS in interspecies and intraspecies bacterial 
competition has been recognized as a prominent feature of the sys‐
tem in a variety of T6SS‐containing bacteria, including P. aeruginosa, 
V. cholerae, and S. marcescens (Hood et al., 2010; MacIntyre et al., 
2010; Murdoch et al., 2011). In this study, we provide evidence to 
support a role for the B. cenocepacia T6SS‐1 in competition against 
two bacterial species, P. putida and E. coli. We have also identified an 
arsenal of potential antibacterial cargo effectors that could be de‐
livered by T6SS‐1, notably including peptidoglycan hydrolases. The 
additional T6SS cluster we identified in B. cenocepacia H111 (T6SS‐7) 
is very unlikely to function in bacterial competition under the con‐
ditions tested, as the bacterial competition experiments performed 
in this study indicated that the level of prey survival was the same in 
the presence of a mutant attacker with an inactive T6SS‐1 as it was 
when there was no B. cenocepacia attacker	strain	present	(Figure	4a).	
Our results are consistent with observations in other species that 
encode a Burkholderia T6SS‐1‐type secretion system. This includes 
the T6SS‐1 in B. thailandensis, which was found to be the sole T6SS 
cluster involved in bacterial competition (Schwarz et al., 2010), and 
the T6SS‐1 homologue in Acinetobacter spp. that was shown to con‐
tribute to interbacterial competition (Basler, Ho, & Mekalanos, 2013; 
Carruthers et al., 2013; Repizo et al., 2015; Weber et al., 2016). 
They are also consistent with recent observations in the related 
Paraburkholderia species P. phymatum, where two non‐T6SS‐1‐type 
secretion systems (T6SS‐3 and T6SS‐b (T6SS‐8)) were found to be 
responsible for interbacterial competition against β‐rhizobia strains 
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in vitro and as a consequence were less efficient in root nodulation 
(de	Campos,	Lardi,	Gandolfi,	Eberl,	&	Pessi,	2017).
The H1‐T6SS in P. aeruginosa PAO1 is thought to be triggered by 
attacks from the T6SS (or T4SS) of neighboring cells as a defensive 
strategy (Basler & Mekalanos, 2012; Basler et al., 2013; Ho, Basler, 
& Mekalanos, 2013). As a result, P. aeruginosa does not display a fit‐
ness advantage over T6SS‐deficient competing species (Basler et 
al., 2013). The T6SSs in S. marcescens Db10 and V. cholerae V52, on 
the other hand, fire indiscriminately and do not require activation 
from a neighboring attacking bacterium, and thereby confer a fit‐
ness	advantage	on	the	host	bacterium	against	various	Gram‐nega‐
tive competitor species, such as a E. coli, Salmonella typhimurium, and 
Pseudomonas fluorescens (Gerc	et	al.,	2015;	MacIntyre	et	al.,	2010).	
Here, we demonstrate that the T6SS‐1 confers a fitness advantage 
on B. cenocepacia over both T6SS‐positive (P. putida KT2440) and 
T6SS‐negative (E. coli SM10(λpir)) bacterial species. This may sug‐
gest that, like S. marcescens and V. cholerae, the T6SS‐1 in B. cenoce‐
pacia is constitutively active and its activation is not stimulated by 
external T6SS attacks, which is also supported by the evidence of 
T6SS activity in wild‐type strains of B. cenocepacia H111 and K56‐2 
under standard laboratory conditions. This would provide additional 
support for the idea that the defensive regulatory strategy used by 
P. aeruginosa	is	atypical	among	T6SSs	(Gerc	et	al.,	2015).	In	addition,	
one of the T6SSs in P. putida KT2440 has been shown to be highly 
efficient at killing phytopathogens such as X. campestris and P. syrin‐
gae	(Bernal,	Allsopp,	Filloux,	&	Llamas,	2017).	However,	our	results	
indicate that B. cenocepacia survival is unaffected by the presence of 
P. putida. The constitutive activity of the T6SS‐1 we have observed 
in B. cenocepacia may account for this, where B. cenocepacia may 
be able to subvert P. putida before P. putida can attack with its own 
T6SS. Alternatively, B. cenocepacia may be immune to the T6SS activ‐
ity of P. putida due to the presence of T6SS immunity proteins with 
interspecies reactivity, as seen for some Tae‐Tai and Tse‐Tsi effec‐
tors–immunity pairs in other species (Russell et al., 2012).
In comparison with the antibacterial T6SSs of other species, the 
fitness advantage of B. cenocepacia over the prey species tested is 
notably less than that observed in several other attacker species, in‐
cluding P. aeruginosa, V. cholerae, and S. marcescens. In these species, 
an active T6SS is responsible for 1,000‐ to 100,000‐fold reduction 
in the number of recovered prey bacteria in a bacterial competition 
assay (Hood et al., 2010; MacIntyre et al., 2010; Murdoch et al., 
2011), whereas we only observed a modest 10‐ to 58‐fold reduction. 
This	observation	may	be	due	to	several	reasons.	For	example,	T6SS	
expression and activity may be lower in B. cenocepacia than these 
other T6SS‐positive strains, the prey strains used in our competition 
assay may produce their own antibacterial factors (such as bacterio‐
cins, siderophores, or effectors secreted by other systems), or there 
may be inherent differences in growth rates between B. cenocepacia 
and the prey species. However, upon enumerating the B. cenocepa‐
cia attacker species in our bacterial competition assays, we found 
that B. cenocepacia survival was not affected by coculture with the 
prey	 species	 (Appendix	 Figure	 A5).	 It	 is	 also	 conceivable	 that	 the	
prey used here may have immunity toward specific T6SS effectors 
due to cross‐reacting T6SS‐immunity proteins between species 
(Russell et al., 2012). It is possible that by screening a larger panel 
of bacterial species, a species may be identified that is more suscep‐
tible to the T6SS‐1‐dependent antibacterial activity of B. cenocepa‐
cia. Moreover, as the T6SS‐1 cluster harbors a number of genes that 
potentially encode post‐translational regulators (i.e., tagF, tagM, and 
tagY), this system may have the capacity to be further upregulated 
under certain conditions.
The B. cenocepacia T6SS‐1 was first implicated in virulence to‐
ward eukaryotes in a signature‐tagged mutagenesis (STM) study 
carried out in a rat model of chronic lung infection in which trans‐
poson insertions within the T6SS‐1 gene cluster were associated 
with impaired survival of the bacterium (Hunt et al., 2004). In subse‐
quent studies, this group demonstrated that the T6SS‐1 contributes 
toward cytoskeletal rearrangements and inflammasome activation 
in B. cenocepacia‐infected	macrophages	 through	host	Rho	GTPase	
inactivation	(Aubert	et	al.,	2008;	Flannagan	et	al.,	2012;	Keith	et	al.,	
2009; Rosales‐Reyes et al., 2012; Xu et al., 2014). In contrast to the 
reported impaired survival of T6SS mutants during rat lung infec‐
tion (Hunt et al., 2004), more recent evidence suggests that the T6SS 
may contribute to a pyrin inflammasome‐dependent innate immune 
response that promotes lung tissue inflammation and bacterial clear‐
ance in a mouse infection model (Aubert et al., 2016; Xu et al., 2014). 
The study by Aubert and co‐workers presented data to show that a 
putative T6SS effector was responsible for this mechanism.
We have tested several T6SS‐inactive strains of B. cenocepacia in 
three eukaryotic host–pathogen models, nematodes, larvae of the 
wax worm, and zebrafish larvae (Seed & Dennis, 2008; Uehlinger 
et al., 2009; Vergunst et al., 2010). We found no significant differ‐
ence in host survival rates in comparison with infection with the WT 
strain in any of these infection models, suggesting that the T6SS‐1 
in B. cenocepacia does not have a functional role in pathogenicity. Of 
note, we have performed our assays in the presence of a functional 
atsR, so the T6SS is not constitutively upregulated as occurs in the 
absence of AtsR, and instead activation above basal levels would de‐
pend on the presence of the appropriate stimulus (as yet unknown) 
in any of the model systems. Therefore, the T6SS is either not ex‐
pressed in these models in the presence of AtsR, or does not con‐
tribute to a significant host‐induced protective immune response, as 
seen in mice (Aubert et al., 2016; Xu et al., 2014). We cannot exclude, 
however, that in the absence of atsR, a measurable effect on viru‐
lence could be detected.
To conclude, we have carried out a bioinformatic and functional 
analysis of the T6SS‐1 in the Bcc species B. cenocepacia. We have 
shown that it is encoded on the large chromosome in nearly all 
Burkholderia species, unlike the other T6SSs associated with mem‐
bers of this genus, which are not conserved in all species and are 
usually specified by chromosome 2. Therefore, T6SS‐1 can be con‐
sidered as the ancestral Burkholderia T6SS and may serve as a marker 
for this genus. We also showed that T6SS‐1 was constitutively active 
in two representative clinical strains and could be used to compete 
against other bacterial species, including P. putida and E. coli. This is 
the first demonstration that T6SS‐1 in a Bcc member plays a role in 
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interbacterial	competition	and	adds	to	the	catalogue	of	Gram‐nega‐
tive bacteria that use the T6SS for this purpose. The natural reservoir 
of B. cenocepacia is within the environment, particularly in the soil 
around plant root systems where many other bacteria compete to 
establish themselves. It is therefore unsurprising that B. cenocepa‐
cia has evolved a mechanism for competitive fitness against other 
bacteria, in a similar manner to other ubiquitous Burkholderia and 
Paraburkholderia species (de Campos et al., 2017; Schwarz et al., 
2010).	 Future	 work	 will	 look	 to	 identify	 and	 characterize	 the	 se‐
creted components responsible for the T6SS‐dependent antibacte‐
rial activity of B. cenocepacia.
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APPENDIX 1
Table A1. Bacterial strains and plasmids used in this study
Strain or plasmid Genotype or description
Source or 
reference
Escherichia coli strains
JM83 F− ara Δ(lac‐proAB) rpsL ϕ80dlacZΔM15 (SmR) (Yanisch‐Perron 
et al., 1985)
SM10(λpir) thi‐1 thr leu tonA lacY supE recA::RP4‐2‐Tc::Mu (KmR) (λpir) (Simon et al., 1983)
S17‐1(λpir) thi proA hsdR recA RP4‐2‐tet::Mu‐1 kan::Tn7 integrant (TpR, 
SmR) (λpir)
(Simon et al., 1983)
CC118(λpir) araD139 Δ(ara‐leu)7697 ΔlacX74 galE galK phoA20 thi‐1 rpsE 
argE(am) recA1 λpir rpoB (Rf
R)
(Herrero et al., 
1990)
OP50 E. coli B uracil auxotroph; food source for C. elegans (Brenner, 1974)
Pseudomonas putida strains
KT2440 Spontaneous r‐ derivative of mt‐2 (Bagdasarian et al., 
1981)
Burkholderia cenocepacia strains
H111 CF	isolate (Römling	et	al.,	
1994)
K56‐2 CF	isolate,	ET12	lineage (Mahenthiralingam 
et al., 2000)
Pc715j CF	sputum	isolate,	ET12	lineage (McKevitt et al., 
1989; Darling 
et al., 1998)
H111‐tssA::Tp H111 with tssA disrupted by dfrB2 cassette (TpR) (Dix et al., 2018)
H111‐tssK::Tp H111 with tssK disrupted by dfrB2 cassette (TpR) This study
H111‐tssM::Tp H111 with tssM disrupted by dfrB2 cassette (TpR) This study
H111‐ΔtssM H111 with an in‐frame deletion of the internal XhoI fragment 
of tssM
(Dix et al., 2018)
H111‐tagY::Tp H111 with tagY disrupted by dfrB2 cassette (TpR) This study
K56‐2‐tssA::Tp K56‐2 with tssA disrupted by dfrB2 cassette (TpR) This study
K56‐2‐tssM::Tp K56‐2 with tssM disrupted by dfrB2 cassette (TpR) This study
Pc715j‐tssA::Tp Pc715j	with	tssA disrupted by dfrB2 cassette (TpR) This study
Pc715j‐tssK::Tp Pc715j	with	tssK disrupted by dfrB2 cassette (TpR) This study
Pc715j‐tssM::Tp Pc715j	with	tssM disrupted by dfrB2 cassette (TpR) This study
Plasmids
pBBR1MCS Mobilizable BHR cloning vector, pBBR1‐replicon (CmR) (Kovach et al., 
1994)
pBluescriptII KS (+) General	cloning	vector,	ColE1‐derived	phagemid,	lacZα MCS 
(ApR)
(Alting‐Mees and 
Short, 1989)
p34E‐Tp p34E	containing	dfrB2 gene (ApR, TpR) (DeShazer and 
Woods, 1996)
pSHAFT2 Suicide vector, R6K‐derived replicon, oriT+ (ApR, CmR) (Shastri et al., 
2017)
pBBR1‐tssK pBBR1MCS containing tssK from B. cenocepacia H111 cloned 
between HindIII and BamHI (CmR)
This study
pBBR1‐tssM’ pBBR1MCS‐1	containing	1.2	kbp	N‐terminal	fragment	of	tssM 
from B. cenocepacia H111 cloned between XbaI and XhoI 
(CmR)
This study
pBBR1‐tssM(+) pBBR1MCS containing full‐length tssM from B. cenocepacia 
H111 cloned between Acc65I and XbaI (CmR)
This study
pBluescriptII‐tagY pBluescriptII containing tagY from B. cenocepacia H111 cloned 
between BamHI and XhoI sites (ApR)
This study
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Strain or plasmid Genotype or description
Source or 
reference
pBBR1‐tssK::Tp pBBR1MCS containing tssK disrupted by dfrB2 cassette at 
EcoRI site in same orientation as tssK (CmR, TpR)
This study
pBBR1‐tssM’::Tp pBBR1MCS containing tssM’ disrupted by dfrB2 cassette at 
BamHI site in reverse orientation as tssM’ (CmR, TpR)
This study
pBluescriptII‐tagY::Tp pBluescriptII containing tagY disrupted by the dfrB2 cassette at 
ZraI site in the same orientation as tagY (ApR)
This study
pSHAFT2‐tssA::Tp pSHAFT2	containing	tssA::Tp allele from pBBR1‐tssA::Tp cloned 
between XhoI and NotI (ApR, CmR, TpR)
(Dix et al., 2018)
pSHAFT2‐tssK::Tp pSHAFT2	containing	tssK::Tp allele from pBBR1‐tssK::Tp cloned 
between XhoI and NotI (ApR, CmR, TpR)
This study
pSHAFT2‐tssM’::Tp pSHAFT2	containing	tssM’::Tp allele from pBBR1‐tssM’::Tp 
cloned between XhoI and NotI (ApR, CmR, TpR)
This study
pSHAFT2‐tagY::Tp pSHAFT2	containing	tagY::Tp allele from pBluescriptII‐tagY::Tp 
cloned between SalI and XbaI (ApR, CmR, TpR)
This study
Abbreviations: ApR, ampicillin‐resistant; CmR, chloramphenicol‐resistant; KmR, kanamycin‐resistant; RfR, rifampicin‐resistant; SmR, strepto‐
mycin‐resistant; TcR, tetracycline‐resistant; TpR, trimethoprim‐resistant; BHR, broad host range.
Table A2. Primers used in this study
Primer ID Primer sequencea
iotAfor 5’‐GCGCAAGCTTCACGCGACATCTCATGCATC
iotArev2 5’‐ATCACGAAGAGCATTCCGCC
tssKfor 5’‐GCGCAAGCTTCCACATTAACCGGATTTGAC	
tssKrev 5’‐GCGCGGATCCTCATGATGTGACCGCGATCA	
tssK‐OPfor 5’‐GCGATTTAATTCGGGCACGA	
tssK‐OPrev 5’‐ACAGCAAATCGAGCAGCGAA	
tssMfor 5’‐GCGCTCTAGAGGAACCTGAACGTCCTATGC	
tssMrev 5’‐GCGCCTCGAGCTGTTGGTTTCGCCTTCCTG	
tssMforAcc65I 5’	‐GCGCGGTACCTTAAAATCGCACCGGAACCTGAAC	
tssMrevXbaI 5’‐GCGCTCTAGAATTTGCGCCTGTACGGTTTG	
tssM‐OPfor 5’‐TCATCCCGTTTGACAGCATG
tssM‐OPrev 5’‐AGAAGCCGTTCTTCGAGAAC
tagYfor 5’‐GCGCCTCGAGTAAAGTGCGCCGGAAAATTCAAA
tagYrev 5’‐GCGCGGATCCCAGTGTCACGCGACATCATA
tagY‐OPfor 5’‐GCGCTCTAGAATCCCCGGAAATTGGAATTG
tagY‐OPrev 5’‐GCGCAAGCTTGGTAAGGAAAGGAGACGTAT
aSequences specifying restriction endonuclease cleavage sites are underlined.
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Table A3. T6SS‐1 gene loci in the Burkholderia genus
Species Strain Chrb Locusa Old locus/aliasa
Burkholderia cepacia complex
B. ambifaria AMMD 1 BAMB_RS01920‐BAMB_RS02010 Bamb_0377‐Bamb_0395
B. anthina AZ‐4‐2‐10‐S1‐D7 1 WS64_RS00645‐WS64_RS00755 WS64_00645‐WS64_00755
B. catarinensis 89 n/a BFF94_26275‐BFF94_35355 n/a
B. cenocepacia J2315 1 QU43_RS38220‐QU43_RS38300 BCAL0337‐BCAL0353
B. cepacia UCB 717 1 APZ15_RS05925‐APZ15_RS06005 APZ15_05925‐APZ15_06005
B. contaminans 170816 1 C3743_RS13835‐ C3743_RS13945 C3743_28295‐C3743_28405
B. diffusa RF2‐non‐BP9	 1 WI26_RS01890‐WI26_RS01990 WI26_01890‐WI26_01990
B. dolosa AU0158 1 AK34_RS26290‐AK34_RS26210 AK34_2669‐AK34_2653
B. lata 383 1 BCEP18194_RS07870‐BCEP18194_
RS07970
Bcep18194_A3555‐Bcep18194_
A3577
B. latens AU17928 1 WK25_RS00385‐WK25_RS00305 WK25_00385‐WK25_00305
B. metallica FL‐6‐5‐30‐S1‐D7 1 WJ16_RS01935‐WJ16_RS02050 WJ16_01935‐WJ16_02050
B. multivorans ATCC 17616 1 BMULJ_RS01495‐BMULJ_RS01645 BMULJ_00300‐BMULJ_00329
B. paludis MSh1 n/a GQ56_0123510‐GQ56_0123430 n/a
B. pseudomultivorans SUB‐INT23‐BP2 1 WS57_RS19835‐WS57_RS19915 WS57_19795‐WS57_19875
B. puraquae CAMPA 1040 n/a B7G54_RS33210‐B7G54_RS33130 B7G54_33195‐B7G54_33115
B. pyrrocinia DSM 10685 1 ABD05_RS07950‐ABD05_RS08030 ABD05_07950‐ABD05_08030
B. seminalis FL‐5‐4‐10‐S1‐D7	 1 WJ12_RS01985‐WJ12_RS02085 WJ12_01985‐WJ12_02085
B. stabilis ATCC BAA‐67 1 BBJ41_RS12095‐BBJ41_RS12210 BBJ41_12095‐BBJ41_12210
B. stagnalis MSMB735 1 WT74_RS02265‐WT74_RS02350 WT74_02260‐WT74_02345
B. territorii RF8‐non‐BP5	 1 WS51_RS12720‐WS51_RS12820 WS51_12715‐WS51_12815
B. ubonensis MSMB22 1 BW23_RS21305‐BW23_RS21205 BW23_1274‐BW23_1254
B. vietnamiensis G4	 1 BCEP1808_RS02265‐BCEP1808_
RS02350
Bcep1808_0456‐Bcep1808_0473
Burkholderia pseudomallei group
B. humptydooensis MSMB122 1 WS76_02215‐WS76_02295 n/a
B. malleic NCTC	10229 1 BMA10229_RS17595‐BMA10229_
RS17645
BMA10229_A1710‐BMA10229_
A1720
B. oklahomensis EO147	 1 DM82_RS14115‐DM82_RS14035 DM82_2790‐DM82_2774
B. pseudomallei K96243 1 BPSL3111‐BPSL3095 AQ15_RS22375‐AQ15_RS22455
B. thailandensis E254	 1 BTH_RS27330‐BTH_RS27250 BTH_I2968‐BTH_I2951
B. singularis LMG	28154 ‐ ‐
Phytopathogens
B. gladioli ATCC 10248 1 BM43_RS25670‐BM43_RS25750 BM43_1793‐BM43_1809
B. glumae BGR1 1 BGLU_RS01925‐BGLU_RS02005 bglu_1g03850‐bglu_1g04010
B. plantarii ATCC 43733 1 bpln_RS01775‐bpln_RS01855 bpln_1g03440‐bpln_1g03600
Abbreviations: Chr, chromosome; n/a, not applicable; ‐, not present.
aGene	loci	refer	to	the	first	(tssL) and last (tagY)	genes	in	the	T6SS‐1	gene	cluster	in	these	species	as	shown	in	Figure	1.
bIf n/a is stated, chromosome location was not available as the loci coordinates were obtained from draft assemblies consisting of contigs.
cTruncated cluster that lacks tssL‐tssD.
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Table A4. Paraburkholderia species containing homologous loci of the Burkholderia T6SS‐1 cluster identified through bioinformatics 
analysis
Species Strain Chrb Locusa Old locus/aliasa
P. acidipaludis NBRC	101816 n/a BAC01S_RS24625‐BAC01S_RS24720 n/a
P. aspalathi LMG	27731 n/a BM438_RS23205‐BM438_RS23285 SAMN05192563_101653‐
SAMN05192563_101669
P. bannensis NBRC	103871 n/a BBA01S_RS03935‐BBA01S_RS03850 n/a
P. bryophila 376MFSha3.1 n/a H281_RS0127575‐H281_RS0127655 n/a
P. caledonica NBRC	102488 n/a BCA01S_RS25625‐BCA01S_RS25545 n/a
P. caribensis DSM 13236 3 C2L66_RS31465‐C2L66_RS31545 C2L66_31465‐C2L66_31545
P. caryophylli Ballard 720 n/a C0Z17_RS09175‐C0Z17_RS09265 C0Z17_09180‐C0Z17_09270
P. dilworthii WSM3556 n/a F759_RS0111885‐F759_RS0111970 n/a
P. eburnea LMG	29537 n/a BX588_RS11555‐BX588_RS30870 BX588_10514‐BX588_1421
P. fungorum GAS106B n/a BLS41_RS32405‐BLS41_RS32325 SAMN05443245_6595‐
SAMN05443245_6579
P. ginsengiterrae DCY85 n/a A6V36_RS34655‐A6V36_RS34735 A6V36_13555‐A6V36_13635
P. graminis C4D1M n/a BGRAMDRAFT_RS31300‐
BGRAMDRAFT_RS31220
BgramDRAFT_6363‐
BgramDRAFT_6347
P. insulsa LMG	28183 n/a BX589_RS19295‐BX589_RS19215 BX589_111106‐BX589_11190
P. kururiensis M130 n/a G118_RS0127045‐G118_RS0127125 n/a
P. megapolitana LMG	23650 n/a BM166_RS27120‐BM166_RS27200 SAMN05192543_109158‐
SAMN05192543_109174
P. nodosa CNPSo	1341 n/a BFD71_RS23080‐BFD71_RS22965 n/a
P. oxyphila NBRC	105797 n/a BO1_RS31110‐BO1_RS23945 n/a
P. phenazinium GAS95 n/a BUS12_RS10920‐BUS12_RS10830 SAMN05444165_2229‐
SAMN05444165_2211
P. phenoliruptrix BR3459a 2 BUPH_RS28500‐BUPH_RS28580 BUPH_06127‐BUPH_06111
P. phytofirmans PsJN 2 BPHYT_RS24375‐BPHYT_RS24455 Bphyt_4909‐Bphyt_4925
P. rhynchosiae WSM 3937 n/a C0Z16_RS18310‐C0Z16_RS18230 C0Z16_18290‐C0Z16_18210
P. sediminicola LMG	24238 n/a BLT79_RS22400‐BLT79_RS22480 SAMN05192547_102957‐
SAMN05192547_102973
P. soli GP25‐8 n/a C0Z19_RS08700‐C0Z19_RS08620 C0Z19_08720‐C0Z19_08640
Paraburkholderia sp. BL18I3N2 n/a B0G75_RS24645‐B0G75_RS24565 B0G75_110100‐B0G75_11084
Paraburkholderia sp. BL21I4N1 n/a B0G83_RS22810‐B0G83_RS22905 B0G83_109119‐B0G83_109138
Paraburkholderia sp. BL25I1N1 n/a B0G73_RS11290‐B0G73_RS11370 B0G73_106134‐B0G73_106151
Paraburkholderia sp. C35 n/a DK391_RS17735‐DK391_RS17655 n/a
Paraburkholderia sp. GV068 n/a C8K18_RS26440‐C8K18_RS26520 C8K18_115102‐C8K18_115118
Paraburkholderia sp. GV072 n/a C8K19_RS26210‐C8K19_RS26130 C8K19_11551‐C8K19_11535
P. symbiotica JPY 581 n/a C0Z20_RS18355‐C0Z20_RS18280 C0Z20_18350‐C0Z20_18275
P. terricola LMG	20594 n/a BUE39_RS22490‐BUE39_RS22570 SAMN05192548_102957‐
SAMN05192548_102973
P. tropica LMG	22274 n/a BMY06_RS23990‐BMY06_RS23890 SAMN05216550_114137‐
SAMN05216550_114117
Abbreviations: Chr, chromosome; n/a, not applicable.
aGene	loci	refer	to	the	first	(tssL) and last (tagY)	genes	in	the	T6SS‐1	gene	cluster	in	these	species	as	shown	in	Figure	1.	P. acidipaludis is an 
exception to this, where the gene loci refer to tssL to tagN.
bIf n/a is stated, chromosome location was not available as the loci coordinates were obtained from draft assemblies consisting of contigs.
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Table A5. Strain‐specific T6SS‐7 gene loci in Burkholderia and related species
Species Strain Chrb Locusa Old locus/aliasa
Burkholderia
B. cenocepacia H111 2 I25_RS17325‐I35_RS17415 I35_0565‐I35_0547
DWS	37E‐2 2 DM40_RS13140‐DM40_RS13060 DM40_4776‐DM40_4759
FL‐5‐3‐30‐S1‐D7 2 WJ11_00625‐WJ11_00725 n/a
VC12308 2 A8E75_RS00805‐A8E75_RS00910 A8E75_00815‐A8E75_00910
D2AES n/a W5I_RS0113450‐W5I_RS0113540 n/a
PC184 Mulks 1c B9Z07_RS01130‐B9Z07_RS01225 B9Z07_01130‐B9Z07_01230
TAtl‐371 n/a BLS50_RS24480‐BLS50_RS24390 SAMN05443026_4796‐
SAMN05443026_4778
B. ambifaria RZ2MS16 n/a AS146_RS14130‐AS146_RS14210 n/a
B. cepacia LK29 14 n/a VL15_RS08940‐VL15_RS08850 VL15_08935‐VL15_08845
B. diffusa MSMB0010 n/a WJ30_RS22370‐WJ30_RS22295 WJ30_23825‐WJ30_23750
B. dolosa AU0158 2 AK34_RS03975‐AK34_RS04060 AK34_3963‐AK34_3981
B. latens AU17928 2 WK25_RS26375‐WK25_RS26295 WK25_26365‐WK25_26285
B. metallica FL‐6‐5‐30‐S1‐D7 2 WJ16_RS22925‐WJ16_RS23015 WJ16_22900‐WJ16_22990
B. 
pseudomulti‐
vorans
MSMB574 n/a WT57_RS16705‐WT57_RS16620 WT57_21995‐WT57_21910
B. puraquae CAMPA 1040 n/a B7G54_RS20355‐B7G54_RS20270 B7G54_20345‐B7G54_20260
B. pyrrocinia MSMB1755 n/a WJ63_RS05815‐WJ63_RS05755 WJ63_27610‐WJ63_27550
B. stabilis LA20W n/a BSLA_02f3182‐BSLA_02r3154 n/a
B. stagnalis MSMB1147 n/a WT05_RS32155‐WT05_RS32230 WT05_32120‐WT05_32195
B. territorii MSMB1917 n/a WT40_RS07200‐WT40_RS07125 WT40_07845‐WT40_07770
B. ubonesis MSMB2006 n/a WK05_RS31815‐WK05_RS31895 WK05_23690‐WK05_23770
B. vietnamiensis FL‐2‐2‐30‐S1‐D0 n/a WJ01_RS25680‐WJ01_RS25595 WJ01_26115‐WJ01_26030
B. glumae BGR1 2 BGLU_RS23295‐BGLU_RS23205 bglu_2g11110‐bglu_2g10910
Species related to Burkholderia
P. tuberum DUS833 n/a BLU10_RS24530‐BLU10_RS24630 SAMN05445850_5072‐
SAMN05445850_5093
C. metallidurans CH34 n/a RMET_RS03120‐RMET_RS03215 Rmet_0617‐Rmet_0637
Abbreviations: Chr, chromosome; n/a, not applicable.
aGene	loci	refer	to	the	first	(tssE) and last (tssJ)	genes	in	the	T6SS‐7	gene	cluster	in	these	species	as	shown	in	Figure	2.
bIf n/a is stated, chromosome location was not available as the loci coordinates were obtained from draft assemblies consisting of contigs.
cChromosome designation may be incorrect for this genome assembly as the largest chromosome has been designated chromosome 3 and 
second	largest	chromosome	1.	Furthermore,	the	nucleotide	sequence	of	chromosome	2	of	PC184	Mulks	shares	significant	sequence	homol‐
ogy with chromosome 1 of B. cenocepacia J2315 and H111, indicating that chromosome 3 should be designated as chromosome 2, which 
would mean the T6SS‐7 cluster is located on chromosome 2 in this strain, as observed in other B. cenocepacia strains.
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APPENDIX 2
FURTHER DE TAIL S REG ARDING CONS TRUC TION OF B .  CEN O CEPACI A  MUTANTS
Primer pairs tssA‐OPfor and tssA‐OPrev, tssK‐OPfor and tssK‐OPrev, tssM‐OPfor and tssM‐OPrev and tagY‐OPfor and tagY‐OPrev were 
used for PCR screening of candidate tssA::Tp, tssK::Tp, tssM::Tp and tagY::Tp mutants, respectively.
F I G U R E  A 1   tagY encodes a predicted transmembrane protein with a periplasmically located C‐terminal domain containing four 
cysteine residues. (A) Amino acid sequence alignment of TagY homologues. The amino acid sequences of TagY homologues identified in B. 
cenocepacia J2315 (BCAL0353), A. arsenitoxydans SY8 (KYC_RS0619), R. gelatinosus	IL144	(RGE_25930),	B. lata	383	(BCEP18194_RS07970),	
B. thailandensis E264	(BTH_RS27250),	X. oryzae	MAFF	311018	(TX61_RS17450)	and	R. solanacearum	GMI1000	(RS_RS20790)	were	aligned	
using	Clustal	W.	Note	that	the	homologue	in	R. solanacearum does not contain the cysteine rich C‐terminal domain. Sequences constituting 
the	predicted	N‐terminal	domain	(NTD),	transmembrane	domain	(TMD),	and	cysteine‐rich	periplasmic	C‐terminal	domain	(CTD)	are	
indicated	by	blue,	red	and	green	boxes,	respectively.	Positively	charged	amino	acids	located	N‐terminal	to	the	TMD	are	shown	in	red	font.	
(B) Schematic representation of the predicted domain arrangement of TagY. The	small	cytoplasmic	NTD	(blue),	TMD	(red),	long	linker	region	
(black) and cysteine‐rich periplasmic CTD (green) are shown.
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F I G U R E  A 2   tagZ encodes a putative 
cytoplasmic membrane protein. (A) 
Schematic representation of the predicted 
topology and transmembrane helices 
within TagZ of B. cenocepacia J2315 
(encoded by BCAL1353), as predicted by 
TMHMM	Server	(v.	2.0).	(B)	N‐terminal	
amino acid sequence alignment of 
TagZ homologues in B. cenocepacia 
J2315 (BCAL1353), B. pseudomallei 
K96243 (BPSL2052), R. gelatinosus 
IL144	(RGE_RS12595),	X. oryzae MAFF	
311018 (TX61_RS17434), P. bannensis 
NBRC	103871	(BBA01S_RS39285),	R. 
solanacearum GMI1000	(RS_RS20775)	
and A. baumannii ATCC 17978 
(AUO97_RS13995). The predicted 
transmembrane helices are enclosed in 
red boxes.
F I G U R E  A 3   tagZ and paar genes associated with the Burkholderia T6SS‐1 are often located within a triple tssI cluster.Schematic 
representation of triple tssI gene clusters identified in the indicated Burkholderia spp. and Paraburkholderia bannensis NBRC	103871,	which	
contain the T6SS‐1‐associated tagZ and paar	genes.	Genes	encoding	putative	T6SS‐lipase	effectors	(tle1), associated lipase immunity 
protein(s) (tli1) and T6SS adaptor proteins (tec/tap‐1) are often present within the cluster.
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F I G U R E  A 4   The T6SS‐7 cluster of B. cenocepacia H111 encodes a putative T6SS type‐5 lipase effector (Tle5) with characteristic dual HxKhhhhD 
sequence motifs.Amino acid sequence alignment of the two regions containing HxKhhhhD catalytic motifs present in putative T6SS‐dependent type‐5 
lipase effector (Tle5) homologues from B. cenocepacia H111 (encoded within the T6SS‐7 cluster at I35_RS17370), B. cenocepacia J2315 (BCAM0149), 
R. solanacearum GMI1000	and	CFBP2957	(RS_RS20135	and	RCFBP_mp20221),	C. violaceum ATCC 12472 (CV_RS06020), C. metallidurans CH42 
(RMET_RS03180),	P. aeruginosa PAO1 (PA5089 and PA3487), A. xylosoxidans A8 (AXYL_RS28255) and S. maltophilia SKK35 (SMSKK35_0837). The dual 
HxKhhhhD motif (where h is an amino acid with a hydrophobic side chain) is characteristic of phospholipase D (PLD) enzymes.
F I G U R E  A 5  Enumeration	of	viable	B. cenocepacia attacker strains in bacterial competition assay.(A) Recovery of viable B. cenocepacia 
H111 ‘attacker’ strains following co‐culture with the indicated prey strains or medium control for 4 hours at 30°C. (B) Comparison of 
recovery of B. cenocepacia H111 WT or ΔtssM mutant attacker strains carrying a complementation or control plasmid (pBBR1‐tssM (ptssM) 
and pBBR1) following co‐culture with E. coli SM10(λpir) prey or medium control. n	≥	3	and	error	bars	indicate	SD.
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F I G U R E  A 6   T6SS‐1 effector loci in the B. cenocepacia J2315 genome.Schematic representation of tssI gene clusters identified in B. 
cenocepacia J2315 and putative T6SS‐dependent effector‐immunity pairs encoded within the clusters (tssI genes are shown in red with 
C‐terminal	coding	sequences	coloured	green	(DUF2345	domain),	brown	(metalloprotease	domain)	or	with	spheres	(lipase_3	domain)	as	
observed previously (Aubert et al., 2015). The BCAL2503 tssI gene contains a deletion that results in its fusion to a divergently orientated 
tssF	gene	and	is	presumably	non‐functional.	Genes	encoding	the	putative	effectors	and	associated	immunity‐protein	are	labelled	and	
filled‐in	with	coloured	spheres	and	dots,	respectively.	Genes	encoding	recognized	T6SS‐adaptor	proteins,	Tec/Tap‐1,	DUF2169‐encoding	
proteins	and	EagR,	and	PAAR‐containing	proteins	are	also	labelled	and	filled	with	diagonal	coloured	stripes	and	orange	horizontal	stripes,	
respectively. tssF homologues are also shown (purple). The BCAM1464‐BCAM1465 tae4‐tai4 effector‐immunity gene pair is not associated 
with a tssI gene cluster.
